Development
Bristol-Myers Squibb Company
BMY
$48.44
$0.631.32%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
--
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 0.62% | -2.25% | -5.56% | -2.67% | -4.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.62% | -2.25% | -5.56% | -2.67% | -4.83% |
| Cost of Revenue | 7.42% | 9.84% | 9.09% | 3.84% | 6.96% |
| Gross Profit | -1.31% | -5.31% | -9.61% | -4.38% | -7.72% |
| SG&A Expenses | -8.67% | 4.87% | 7.95% | -3.66% | -3.50% |
| Depreciation & Amortization | -2.77% | -6.70% | -6.62% | -6.66% | -3.06% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.12% | 0.81% | 1.84% | 0.38% | 0.00% |
| Operating Income | 10.10% | -13.31% | -29.34% | -12.07% | -24.62% |
| Income Before Tax | -9.95% | -3.26% | -5.06% | 64.20% | 0.05% |
| Income Tax Expenses | 46.99% | -66.22% | -141.21% | 24.50% | 67.70% |
| Earnings from Continuing Operations | -12.99% | 20.27% | 45.35% | 76.70% | -14.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 100.00% | -200.00% | 50.00% | 0.00% | -- |
| Net Income | -12.86% | 20.05% | 45.88% | 77.00% | -14.76% |
| EBIT | 10.10% | -13.31% | -29.34% | -12.07% | -24.62% |
| EBITDA | 3.60% | -10.25% | -17.12% | -9.88% | -15.36% |
| EPS Basic | -9.37% | 24.49% | 48.66% | 80.97% | -10.95% |
| Normalized Basic EPS | 21.26% | -5.83% | -19.43% | -0.78% | -19.49% |
| EPS Diluted | -8.94% | 24.00% | 50.00% | 81.36% | -11.42% |
| Normalized Diluted EPS | 21.84% | -5.49% | -19.18% | -0.61% | -19.49% |
| Average Basic Shares Outstanding | -3.84% | -3.56% | -1.88% | -2.19% | -4.27% |
| Average Diluted Shares Outstanding | -4.28% | -3.91% | -2.19% | -2.36% | -4.28% |
| Dividend Per Share | 5.26% | 5.56% | 5.56% | 5.56% | 5.56% |
| Payout Ratio | 0.16% | -0.14% | -0.29% | -0.43% | 0.22% |